ANIK logo

Anika Therapeutics Inc


ANIK: Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.


Show ANIK Financials

Consumer Interest
SEC Filings

Recently reported changes by institutional investors

Quarterly net insider trading by ANIK's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $10,000 Oct 21, 2016 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: Methods and compositions for treating tendon degeneration Oct. 15, 2019
  • Patent Title: Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid Dec. 04, 2012
  • Patent Title: Crosslinked hyaluronic acid compositions for tissue augmentation Feb. 28, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ANIK in WallStreetBets Daily Discussion


Recent insights relating to ANIK

CNBC Recommendations

Recent picks made for ANIK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ANIK

Corporate Flights

Flights by private jets registered to ANIK